T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
SI-BONE Inc
SIBN
$847M
| $171K | ﹤0.01% |
12,949
+1,712
| +15% | +$28.5K |
|
2627
Karyopharm Therapeutics
KPTI
$44.9M
| $170K | ﹤0.01% |
2,511
+758
| +43% | +$69.5K |
|
2628
Ribbon Communications
RBBN
$379M
| $170K | ﹤0.01% |
56,081
+407
| +0.7% | +$1.23K |
|
2629
Vipshop
VIPS
$6.73B
| $169K | ﹤0.01% |
17,100
| – | – |
|
|
MAGN
2630
Magnera Corp
MAGN
$434M
| $169K | ﹤0.01% |
1,885
+23
| +1% | +$2.76K |
|
2631
Oil States International
OIS
$531M
| $168K | ﹤0.01% |
31,041
+5,115
| +20% | +$35.7K |
|
2632
Tencent Music
TME
$14B
| $168K | ﹤0.01% |
33,400
| – | – |
|
2633
Marathon Digital Holdings
MARA
$3.58B
| $167K | ﹤0.01% |
31,334
+1,222
| +4% | +$16.3K |
|
|
ARC
2634
DELISTED
ARC Document Solutions, Inc.
ARC
| $167K | ﹤0.01% |
63,502
| – | – |
|
2635
Fossil Group
FOSL
$327M
| $166K | ﹤0.01% |
32,191
+6,300
| +24% | +$51K |
|
2636
Rackspace Technology
RXT
$1.08B
| $166K | ﹤0.01% |
23,103
+367
| +2% | +$3.31K |
|
2637
Aptevo Therapeutics
APVO
$5.21M
| – | – |
0
| – | – |
|
2638
Atea Pharmaceuticals
AVIR
$418M
| $164K | ﹤0.01% |
23,081
-422,879
| -95% | -$2.89M |
|
2639
Mitek Systems
MITK
$839M
| $163K | ﹤0.01% |
17,645
+200
| +1% | +$2.13K |
|
2640
UWM Holdings
UWMC
$2.57B
| $163K | ﹤0.01% |
46,145
-9,252
| -17% | -$35.5K |
|
2641
Citizens
CIA
$201M
| $162K | ﹤0.01% |
38,700
+13,915
| +56% | +$50.2K |
|
2642
Kodak
KODK
$986M
| $162K | ﹤0.01% |
34,955
-4,792
| -12% | -$25K |
|
2643
Cadiz
CDZI
$296M
| $160K | ﹤0.01% |
68,572
-984
| -1% | -$2.05K |
|
2644
Golub Capital BDC
GBDC
$3.47B
| $156K | ﹤0.01% |
12,000
| – | – |
|
|
FIRY
2645
Firy Inc
FIRY
$160M
| $156K | ﹤0.01% |
6,308
+3,178
| +102% | +$124K |
|
|
LUNA
2646
DELISTED
Luna Innovations Incorporated
LUNA
| $156K | ﹤0.01% |
26,700
+4,753
| +22% | +$28K |
|
|
BHR
2647
Braemar Hotels & Resorts
BHR
$140M
| $154K | ﹤0.01% |
35,823
+4,383
| +14% | +$24.8K |
|
2648
Acacia Research
ACTG
$450M
| $153K | ﹤0.01% |
30,300
-4,495
| -13% | -$20.6K |
|
2649
Riot Platforms
RIOT
$7.43B
| $153K | ﹤0.01% |
36,492
+1,317
| +4% | +$12.2K |
|
2650
Veritone
VERI
$137M
| $153K | ﹤0.01% |
23,476
+822
| +4% | +$8.29K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.